151 related articles for article (PubMed ID: 21410071)
1. Pilot study of systemic combination therapy with S-1, an oral fluoropyrimidine, and cisplatin for hepatocellular carcinoma with extrahepatic metastases.
Katamura Y; Aikata H; Hashimoto Y; Kimura Y; Kawaoka T; Takaki S; Waki K; Hiramatsu A; Kawakami Y; Takahashi S; Chayama K
Hepatogastroenterology; 2010; 57(102-103):1272-8. PubMed ID: 21410071
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases.
Uka K; Aikata H; Mori N; Takaki S; Kawakami Y; Azakami T; Kawaoka T; Jeong SC; Takahashi S; Chayama K
Oncology; 2008; 75(1-2):8-16. PubMed ID: 18719349
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis.
Nakamura M; Nagano H; Marubashi S; Miyamoto A; Takeda Y; Kobayashi S; Wada H; Noda T; Dono K; Umeshita K; Monden M
Cancer; 2008 Apr; 112(8):1765-71. PubMed ID: 18327806
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience of chemotherapy with S-1/CDDP for highly-advanced gastric cancer].
Uchima Y; Kosaka K; Kimura K; Okita Y; Sim JK; Aomatsu N; Hirata K; Lee WH; Lee T; Nishii T; Tei S; Takeuchi K
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1287-90. PubMed ID: 20647711
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and toxicity of S-1 plus cisplatin combination neoadjuvant chemotherapy in patients with oral cancer.
Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Mizuno A
Gan To Kagaku Ryoho; 2011 Jun; 38(6):951-7. PubMed ID: 21677485
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of S-1 plus weekly CDDP for advanced gastric cancer].
Kemmochi T; Egawa T; Mihara Y; Irino T; Ito Y; Nagashima A; Makino H; Yamamuro W
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2351-3. PubMed ID: 22202379
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy of S-1/low-dose CDDP/lentinan for advanced gastric cancer].
Hori T; Ikehara T; Takatsuka S; Fukuoka T; Tendo M; Tezuka K; Dan N; Nishino H; Hirakawa K
Gan To Kagaku Ryoho; 2011 Feb; 38(2):293-5. PubMed ID: 21368498
[TBL] [Abstract][Full Text] [Related]
8. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
[TBL] [Abstract][Full Text] [Related]
11. [A pilot study of TS-1 combined with cisplatin in patients with advanced gastric cancer].
Iwase H; Shimada M; Nakamura M; Iyo T; Nakarai K; Kaida S; Indo T; Okeya M; Mizuno T; Ina K; Kusugami K
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1575-82. PubMed ID: 12355943
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.
Kim SJ; Han SW; Oh DY; Yi NJ; Kim YJ; Im SA; Yoon JH; Kang GH; Suh KS; Bang YJ; Jang JJ; Kim TY
Anticancer Res; 2010 Dec; 30(12):5245-50. PubMed ID: 21187521
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma.
Furuse J; Okusaka T; Kaneko S; Kudo M; Nakachi K; Ueno H; Yamashita T; Ueshima K
Cancer Sci; 2010 Dec; 101(12):2606-11. PubMed ID: 20946314
[TBL] [Abstract][Full Text] [Related]
15. [The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Narita T; Seshimo A; Itabashi M; Aratake K; Ogawa S; Hirosawa T; Hashimoto T; Amano K; Kameoka S
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1821-4. PubMed ID: 22083190
[TBL] [Abstract][Full Text] [Related]
16. A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen.
Sato Y; Kondo H; Honda K; Takahari D; Sumiyoshi T; Tsuji Y; Yoshizaki N; Niitsu Y
Int J Clin Oncol; 2005 Feb; 10(1):40-4. PubMed ID: 15729600
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
[TBL] [Abstract][Full Text] [Related]
19. [A case report of S-1 monotherapy for advanced hepatocellular carcinoma].
Yamashita T; Arai K; Terashima T; Sunagozaka H; Shimakami T; Yamashita T; Mizukoshi E; Sakai A; Honda M; Kaneko S
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1435-7. PubMed ID: 22996786
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of patients with advanced gastric cancer undergoing S-1/CDDP combined neoadjuvant chemotherapy].
Kikuchi D; Ishii Y; Saitou M; Yamada M; Takenoshita S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1113-7. PubMed ID: 21772093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]